In contrast, APOA4 concentrations are markedly increased in chronic kidney disease (CKD), mainly in dialysis patients, resulting in a potential early marker of renal impairment that can predict CKD progression [42]. This evidence concerns the gene APOA4 and chronic kidney disease.